BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  HUYABIO INTERNATIONAL ANNOUNCES INITIATION OF HBI-3000 PHASE 2 TRIAL

  HUYABIO International today announced that the first three patients had been dosed in an ongoing Phase 2 study of HUYABIO’s novel drug for pharmacological cardioversion of atrial fibrillation (AF).

  June 14, 2022

   · 

  2 min read
• Pharm Country

  Top Local Changemakers Addressing Health Equity Gaps Across the U.S. Named Johnson & Johnson Health Equity Innovation Challenge Awardees

  After an extensive search for the top changemakers in six key U.S. cities, Johnson & Johnson announced the 14 awardees of its Health Equity Innovation Challenge.

  June 14, 2022

   · 

  9 min read
• Biotech Bay

  NEUSPERA MEDICAL® ANNOUNCES SECOND PHASE OF SANS-UUI IDE CLINICAL TRIAL WITH THE NUVELLA™ SYSTEM

  Pivotal trial to study the safety and efficacy of sacral nerve stimulation in patients with urinary urgency incontinence symptoms.

  June 14, 2022

   · 

  2 min read
• Biotech Beach

  Biological Dynamics Selected as Finalist for the 2022 AACC Disruptive Technology Award

  Award Recognizes the Company’s Verita ™ Isolation Platform, which Enables Early-Stage Cancer Detection.

  June 14, 2022

   · 

  2 min read
• Genetown

  Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O®

  Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O ® .

  June 14, 2022

   · 

  11 min read
• Pharm Country

  Applied UV Installs Patented LumiCide Surface Disinfection Solution into NYC’s Mt. Sinai Medical Center Morningside

  Applied UV, Inc. and automatically, announces that its wholly owned subsidiary SteriLumen has just installed its patented LumiCide Surface and Drain UVC Disinfecting Systems initially, in 17 patient rooms within the world renowned Mt. Sinai Medical Center Morningside.

  June 14, 2022

   · 

  7 min read
• Drug Development

  Exscientia Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A2A Receptor Signaling Inhibition in Healthy Volunteers

  Exscientia Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A 2A Receptor Signaling Inhibition in Healthy Volunteers.

  June 14, 2022

   · 

  6 min read
• Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep ApneaStudy Recently Presented at the SLEEP 2022 Annual Meeting

  Vivos Therapeutics, Inc today announced that the Company presented positive results from a retrospective study with Vivos patients at this year’s SLEEP 2022.

  June 14, 2022

   · 

  5 min read
• Business

  Moderna Appoints DXTRA Health Integrated Solutions as Global Corporate AOR

  DXTRA Health Integrated Solutions has been appointed by Moderna as the brand’s global enterprise agency of record.

  June 14, 2022

   · 

  2 min read
• Business

  LivaNova Elects Peter Wilver to Board of Directors

  LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Peter Wilver has been elected to the Board of Directors, effective immediately.

  June 14, 2022

   · 

  2 min read